Aegerion CEO on Cholesterol Drug Lomitapide

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

Oct. 18 (Bloomberg) -- Marc Beer, chief executive officer of Aegerion Pharmaceuticals Inc., talks about the company's lomitapide drug to treat the most life-threatening forms of high cholesterol. A U.S. Food and Drug Administration panel supported the use of the drug. Beer speaks with Pimm Fox on Bloomberg Television's "Taking Stock." (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change